Source Ethylene Oxide Sterilized Butterfly Needle for Blood Collection, IV Therapy, and Infusion

Ethylene Oxide Sterilized Butterfly Needle Sourcing Guide

Procuring ethylene oxide sterilized butterfly needles requires a disciplined approach to balancing clinical safety with commercial viability. These devices are specialized tools designed primarily for blood collection, offering a flexible alternative to standard vacutainer systems for patients with difficult venous access. The core value proposition lies in the combination of a sterile, single-use design with customizable features such as logo printing and specific gauge selections. Buyers must navigate a market where product attributes vary significantly between suppliers, necessitating rigorous verification of sterilization methods, material composition, and packaging integrity before committing to volume orders.

The sourcing landscape for these medical devices is characterized by a wide range of observed listing signals, including price points that appear unusually low and minimum order quantities (MOQs) that can scale from 1,000 to 300,000 units. This variance suggests a mix of direct manufacturers, trading companies, and potentially different tiers of quality within the same product category. Consequently, procurement teams must look beyond surface-level listing details and focus on verifiable technical specifications and compliance documentation. Understanding the underlying supply chain dynamics is essential to avoid pitfalls related to inconsistent quality, delayed lead times, or non-compliant sterilization processes that could jeopardize clinical outcomes and regulatory standing.

Product Scope and Observed Listing Signals

The product scope for ethylene oxide sterilized butterfly needles encompasses a variety of configurations tailored to different clinical needs and branding requirements. Observed listings indicate that these needles are typically constructed from plastic components, with color-coding options such as grey, orange, purple, blue, black, green, yellow, and beige to denote specific gauges. The standard gauges available in the market range from 18G to 25G, allowing for precise selection based on vein size and blood viscosity. Additionally, tube lengths are commonly available in 18cm and 30cm variants, providing flexibility for different procedural setups. Buyers should verify that the specific model numbers, such as N-B01, N-B03, TOP-BCN, or CY114, align with their internal inventory systems and clinical protocols.

Listing signals also reveal significant variation in packaging and branding options, which can impact both logistics and brand visibility. Some suppliers offer packaging in bags of 100 pieces per carton of 5,000, while others provide boxes of 100 with 50 boxes per carton. The availability of logo printing, both with and without customization, allows hospitals and distributors to maintain brand consistency. However, the observed price range of 0-0.9 USD per unit is exceptionally low and may indicate bulk pricing for high-volume orders or potentially lower-tier manufacturing standards. Procurement teams must treat these price points as indicative rather than definitive, ensuring that cost savings do not come at the expense of sterility assurance or material quality.

Technical Specifications to Verify

Technical verification begins with confirming the sterilization method, as ethylene oxide (EO) sterilization is a critical requirement for many clinical environments due to its effectiveness on heat-sensitive materials. Buyers must ensure that the supplier explicitly states EO sterilization and provides evidence of proper aeration to minimize residual ethylene oxide levels. The quality guarantee period is typically listed as two years, which sets the expectation for shelf-life management and inventory turnover. Additionally, the sterile condition of the product must be guaranteed, with packaging designed to maintain sterility until the point of use. Any deviation from these standards can compromise patient safety and regulatory compliance.

Material and dimensional specifications are equally important for ensuring compatibility with existing blood collection systems. The needles are often described with specific model identifiers and standard gauge listings, such as 18G, 20G, 21G, 22G, 23G, 24G, and 25G. Buyers should verify the needle length, which is observed to be 19mm or 25mm, and the tube length, which is typically 18cm or 30cm. These dimensions must match the requirements of the clinical staff and the equipment used in blood collection procedures. Furthermore, the material composition, primarily plastic for the housing and tubing, should be biocompatible and free from harmful additives. Confirming these details prevents mismatches in clinical settings and ensures smooth integration into existing workflows.

Compliance and Safety Documentation

Compliance documentation is the cornerstone of safe procurement for medical devices. Buyers must request and verify certificates such as CE and ISO 13485, which indicate adherence to quality management systems specific to medical devices. The presence of these certifications suggests that the supplier has implemented rigorous controls over their manufacturing processes, from raw material sourcing to final product release. However, buyers should not assume that all listed products automatically meet these standards; each batch or model should be cross-referenced with the supplier’s current certification status. This verification process helps mitigate the risk of sourcing non-compliant products that could lead to regulatory penalties or clinical incidents.

In addition to general certifications, specific standards related to blood collection devices should be reviewed. While some background information mentions ISO 7864 and ISO 9626, buyers must confirm that the supplier’s products meet the relevant international or regional standards for safety and performance. The origin of the products, often listed as China, Shandong, or Anqing, should be transparently disclosed, and buyers should assess the regulatory environment of the manufacturing location. Understanding the supply chain’s geographical context helps in evaluating the reliability of the supplier and the consistency of their quality control measures. Proper documentation ensures that the procurement process aligns with both internal policies and external regulatory requirements.

Cost Drivers and Commercial Terms

Cost drivers for ethylene oxide sterilized butterfly needles include the complexity of the sterilization process, the volume of the order, and the level of customization required. High-volume orders, with MOQs ranging from 1,000 to 300,000 units, typically benefit from economies of scale, resulting in lower per-unit costs. However, buyers must consider the total cost of ownership, which includes shipping, handling, and potential storage costs due to the two-year shelf life. The observed lead time of 20 days after payment receipt is a critical factor in supply chain planning, as delays can disrupt clinical operations. Buyers should negotiate clear terms regarding lead times and penalties for delays to ensure timely delivery.

Commercial terms also encompass shipping methods and packaging efficiency. Suppliers offer various shipping options, including railway, sea, and air freight, each with different cost and time implications. Sea freight is generally more cost-effective for large volumes but takes longer, while air freight is faster but more expensive. The packaging format, whether in bags, boxes, or cartons, affects the density of the shipment and thus the freight cost. Buyers should optimize their order quantities and shipping methods to balance cost efficiency with delivery speed. Additionally, the availability of logo printing may incur additional costs, which should be factored into the overall budget. Transparent commercial terms help in accurate cost forecasting and budget management.

Supplier Qualification and Quality Control

Supplier qualification involves a thorough assessment of the manufacturer’s capabilities and quality control systems. Buyers should verify the supplier’s production capacity, which is observed to be up to one million units per day, indicating a robust manufacturing infrastructure. This capacity suggests that the supplier can handle large orders without compromising quality or delivery schedules. However, buyers must also assess the supplier’s quality control processes, including in-process inspections and final product testing. A reliable supplier will have documented procedures for monitoring critical parameters such as sterilization efficacy, material integrity, and packaging seal strength.

Quality control extends to the supplier’s ability to maintain consistency across batches. Buyers should request samples for initial evaluation and conduct periodic audits of the manufacturing facility if possible. The supplier’s response to quality issues and their commitment to continuous improvement are key indicators of their reliability. Additionally, the supplier’s transparency regarding their supply chain, including raw material sourcing and subcontracting practices, is essential for assessing risk. A qualified supplier will provide detailed information about their quality management system and be willing to collaborate on resolving any quality concerns. This proactive approach ensures that the procurement process is supported by a partner committed to delivering high-quality medical devices.

Long-Term Procurement Checks

Long-term procurement checks focus on maintaining a sustainable and compliant supply chain. Buyers should establish regular review cycles to assess supplier performance, including delivery reliability, product quality, and responsiveness to issues. Continuous monitoring helps in identifying potential risks early and implementing corrective actions before they impact clinical operations. The two-year quality guarantee period requires buyers to manage inventory carefully to avoid expiration, ensuring that stock is rotated efficiently. Regular audits of the supplier’s compliance status, including certifications and regulatory updates, are necessary to maintain alignment with evolving standards.

Furthermore, buyers should foster a collaborative relationship with their suppliers to drive continuous improvement. This includes sharing feedback on product performance and discussing potential innovations or enhancements. Long-term contracts can provide stability and predictability, but they should include clauses for periodic review and adjustment based on market conditions and performance metrics. By maintaining a proactive and engaged approach to supplier management, buyers can ensure a steady supply of high-quality ethylene oxide sterilized butterfly needles that meet the needs of their clinical teams and patients. This strategic focus on long-term partnerships supports operational efficiency and patient safety over time.